Sectors

Data Insights

Venglustat malate by Sanofi for Gaucher Disease Type III: Likelihood of Approval

Data Insights

EVX-02 by Evaxion Biotech for Melanoma: Likelihood of Approval

Data Insights

TDM-105795 by Technoderma Medicines for Androgenic Alopecia: Likelihood of Approval

Data Insights

(Chlorthalidone + losartan) by Laboratorios Silanes for Idiopathic (Essential) Hypertension: Likelihood of Approval

Data Insights

SHJ-002 by Sunhawk Vision Biotech for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval

Data Insights

Alimta by Eli Lilly and Co for Chordoma: Likelihood of Approval

Data Insights

Vesigel by UroGen Pharma for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval

Data Insights

Hymecromone by Halo Biosciences for Primary Sclerosing Cholangitis: Likelihood of Approval

Clinical Trials

News

Seres’ SER-155 gains breakthrough status for BSIs reduction

Partner Content

CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System

News

Does Southeast Asia have a growing role in vaccine development?

Drug Manufacturers

News

Thermo Fisher counters tariffs with $2bn investment into US manufacturing

Partner Content

3 reasons why biotechs preparing for launch need a compliant content foundation

News

Novartis commits $23bn to US manufacturing amid tariff threats

Therapy Area

News

UK MHRA authorises BridgeBio’s acoramidis for ATTR-CM

News

Biohaven secures $600m financing as it awaits FDA prodrug decision

News

EC conditionally approves Regeneron’s Lynozyfic for multiple myeloma

Pricing and Market Access

Analyst Comment

First two medicinal products to undergo EU joint clinical assessments announced

Features

IRA holds the scope to shape pharma’s research strategy, say experts

Analyst Comment

International Reference Pricing (IRP) 2024: A year in review

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close